 Kiniksa Pharmaceuticals NASDAQ:KNSA was upgraded by BidaskClub from a hold rating to a buy rating in a note issued to investors on Wednesday, BidAskClub reports. Several other equities analysts have also commented on KNSA. Bank of America began coverage on Kiniksa Pharmaceuticals in a research report on Wednesday, April 1st. They set a buy rating ... 